| Lithium Plus Minerals Ltd (LPM) ORDINARY FULLY PAID |
Materials |
$16 |
DRX: Proposed sale of Clermont Gold Project
|
28 Aug 2025 8:58AM |
$0.078 |
$0.120 |
risen by
53.85%
|
|
| Diatreme Resources Limited (DRX) ORDINARY FULLY PAID |
Materials |
$85 |
Proposed sale of Clermont Gold Project
|
28 Aug 2025 8:58AM |
$0.020 |
$0.017 |
fallen by
15%
|
|
DRX - Price-sensitive ASX Announcement
Full Release
Key Points
- Diatreme to divest Clermont Gold Project to Moonlight Resources.
- Moonlight targeting rapid resource delineation and IPO on ASX.
- Diatreme to receive A$3.25 million in shares and A$250,000 in cash.
- Diatreme to hold 17.1% to 19.9% stake in Moonlight post-IPO.
- Conditions for sale include due diligence and regulatory approvals.
- Diatreme focuses on silica assets, transitioning Clermont to Moonlight.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Diatreme Resources Limited (DRX) ORDINARY FULLY PAID |
Materials |
$85 |
Proposed sale of Clermont Gold Project
|
28 Aug 2025 8:58AM |
$0.020 |
$0.017 |
fallen by
15%
|
|
DRX - Price-sensitive ASX Announcement
Full Release
Key Points
- Diatreme sells Clermont Gold Project to Moonlight Resources.
- Transaction involves shares and performance rights valued at A$3.25 million plus A$250,000 in cash.
- Moonlight aims for rapid resource delineation and ASX listing by end of 2025.
- Diatreme retains significant shareholder status in Moonlight.
- Transaction subject to due diligence and regulatory approvals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gemlife Communities Group (GLF) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,669 |
1H FY25 Appendix 4D and Financial Reports
|
28 Aug 2025 8:57AM |
$4.650 |
$4.390 |
fallen by
5.59%
|
|
| DXN Limited (DXN) ORDINARY FULLY PAID |
Information Technology |
$7 |
Appendix 4E and Annual Report
|
28 Aug 2025 8:57AM |
$0.065 |
$0.021 |
fallen by
67.69%
|
|
DXN - Price-sensitive ASX Announcement
Full Release
Key Points
- DXN Limited reported a comprehensive loss of AUD 2.31 million for the year.
- Revenue increased to AUD 16.03 million, primarily from data centre manufacturing.
- Major expenses included depreciation, amortization, and employee benefits.
- Total assets amounted to AUD 16.15 million; liabilities were AUD 11.23 million.
- Net assets stood at AUD 4.92 million as of 30 June 2025.
- Share-based payments and options issuance were significant during the year.
- Liquidity management and financial risk strategies were emphasized.
- Changes in key management personnel were noted in the report.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| DXN Limited (DXN) ORDINARY FULLY PAID |
Information Technology |
$7 |
Appendix 4E and Annual Report
|
28 Aug 2025 8:57AM |
$0.065 |
$0.021 |
fallen by
67.69%
|
|
DXN - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 49% to $16.03 million.
- Net loss after tax was $2.31 million.
- EBITDA of $5,769 and Underlying EBITDA of $814,526.
- No dividends were paid or declared during the year.
- Expansion into Data Centre as a Service (DCaaS) division.
- Geographical expansion prioritized in the APAC region.
- The financial statements were audited with an unmodified opinion.
- Focus on targeting high-growth segments in digital infrastructure.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Amotiv Limited (AOV) ORDINARY FULLY PAID |
Consumer Discretionary |
$922 |
Update - Notification of buy-back - AOV
|
28 Aug 2025 8:57AM |
$9.710 |
$6.890 |
fallen by
29.04%
|
|
| Eagers Automotive Limited (APE) ORDINARY FULLY PAID |
Consumer Discretionary |
$6,689 |
2025 Half Year Results Presentation
|
28 Aug 2025 8:57AM |
$22.550 |
$23.690 |
risen by
5.06%
|
|
| Eagers Automotive Limited (APE) ORDINARY FULLY PAID |
Consumer Discretionary |
$6,689 |
2025 Half Year Results Announcement
|
28 Aug 2025 8:56AM |
$22.550 |
$23.690 |
risen by
5.06%
|
|
| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$285 |
Update - Notification of buy-back - AMH
|
28 Aug 2025 8:56AM |
$1.080 |
$0.900 |
fallen by
16.67%
|
|
| Omni Bridgeway Limited (OBL) ORDINARY FULLY PAID US PROHIBITED |
Financials |
$504 |
FY25 Corporate Governance Statement and Appendix 4G
|
28 Aug 2025 8:56AM |
$1.555 |
$1.740 |
risen by
11.90%
|
|
| Eagers Automotive Limited (APE) ORDINARY FULLY PAID |
Consumer Discretionary |
$6,689 |
Dividend/Distribution - APE
|
28 Aug 2025 8:56AM |
$22.550 |
$23.690 |
risen by
5.06%
|
|
| Metallium Limited (MTM) ORDINARY FULLY PAID |
Materials |
$505 |
Exercise of performance rights & share sale for tax planning
|
28 Aug 2025 8:56AM |
$0.795 |
$0.685 |
fallen by
13.84%
|
|
| Ramsay Health Care Limited (RHC) ORDINARY FULLY PAID |
Health Care |
$9,764 |
Investor Presentation & Speech FY25 Results Briefing
|
28 Aug 2025 8:55AM |
$38.090 |
$42.300 |
risen by
11.05%
|
|
RHC - Price-sensitive ASX Announcement
Full Release
Key Points
- FY25 results highlight Ramsay Health Care's transformation strategy.
- Focus on expanding procedural capacity and telehealth in Australia.
- Strong performance from Australian and UK hospitals.
- Challenges in Elysium and Ramsay Santé noted.
- 6.5% increase in underlying NPAT growth for the Funding Group.
- Leverage ratios remain within target range.
- Strategic priorities include capital discipline and 'People caring for People' culture.
- Investments in digital and AI for enhanced healthcare delivery.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ramsay Health Care Limited (RHC) ORDINARY FULLY PAID |
Health Care |
$9,764 |
Investor Presentation & Speech FY25 Results Briefing
|
28 Aug 2025 8:55AM |
$38.090 |
$42.300 |
risen by
11.05%
|
|
RHC - Price-sensitive ASX Announcement
Full Release
Key Points
- Strong revenue growth driven by activity growth in Australia and the UK.
- EBIT impacted by lower earnings from Elysium.
- Net financing costs declined due to lower net debt levels post-sale of RSD.
- ROCE reflects flat earnings on higher capital employed.
- Leverage ratio within target range and covenants.
- Solid performance in Australian private hospitals.
- UK hospitals showed improved performance driven by NHS volume.
- Elysium underwent restructuring with a focus on telehealth expansion.
- Ramsay Santé focused on disciplined capital management and strategic options evaluation.
- New leadership structure and strategic initiatives for Australian transformation.
- Continued focus on operational excellence across all regions.
- Introduction of 'Big 5' hospital operational initiatives.
- Improved revenue indexation and operational improvements in private hospitals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Eagers Automotive Limited (APE) ORDINARY FULLY PAID |
Consumer Discretionary |
$6,689 |
2025 Half Yearly Report and Accounts
|
28 Aug 2025 8:55AM |
$22.550 |
$23.690 |
risen by
5.06%
|
|
APE - Price-sensitive ASX Announcement
Full Release
Key Points
- Net profit after tax of $134.2 million for the half year ended June 30, 2025.
- Total revenue from external customers amounted to $6.5 billion.
- Major revenue sources include new vehicles, used vehicles, parts, and services.
- The company's operations are primarily based in Australia and New Zealand.
- Total assets of $5.9 billion and total liabilities of $4.6 billion.
- Equity attributable to owners amounts to $1.35 billion.
- Significant business acquisitions, divestments, and integration costs.
- Strategic focus on growth and profitability.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Omni Bridgeway Limited (OBL) ORDINARY FULLY PAID US PROHIBITED |
Financials |
$504 |
FY25 Full Year Results Investor Presentation
|
28 Aug 2025 8:55AM |
$1.555 |
$1.740 |
risen by
11.90%
|
|
OBL - Price-sensitive ASX Announcement
Full Release
Key Points
- Net profit after tax (NPAT) was A$416.8 million.
- Total revenue for FY25 was A$471.2 million.
- Deconsolidation of Funds 2 and 3 improved balance sheet valuation.
- Fair value adjustments contributed significantly to income.
- The portfolio includes over 300 active investments.
- Omni Bridgeway is a global leader in litigation funding.
- The company received high industry recognition in 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Omni Bridgeway Limited (OBL) ORDINARY FULLY PAID US PROHIBITED |
Financials |
$504 |
FY25 Full Year Results Investor Presentation
|
28 Aug 2025 8:55AM |
$1.555 |
$1.740 |
risen by
11.90%
|
|
OBL - Price-sensitive ASX Announcement
Full Release
Key Points
- Total statutory income of A$77.4 million, up 43% from FY23.
- NPAT increased to A$18.9 million.
- Employee expenses reduced by 18% to A$28.1 million.
- Total income of A$651.2 million.
- Platform expenses managed at A$84.1 million.
- Assets under management at A$5.2 billion.
- Achieved 2.5x MOIC across 60 full and partial completions.
- Investment portfolio includes over 300 active investments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| South32 Limited (S32) ORDINARY FULLY PAID |
Materials |
$20,728 |
Appendix 4G - Key to Disclosures
|
28 Aug 2025 8:55AM |
$2.910 |
$4.620 |
risen by
58.76%
|
|
| Omni Bridgeway Limited (OBL) ORDINARY FULLY PAID US PROHIBITED |
Financials |
$504 |
FY25 Appendix 4E and Annual Report
|
28 Aug 2025 8:55AM |
$1.555 |
$1.740 |
risen by
11.90%
|
|
OBL - Price-sensitive ASX Announcement
Full Release
Key Points
- Establishment of Fund 9 resulting in a deconsolidation gain.
- Total comprehensive income for the year was $452.2 million.
- Significant proceeds and payments related to litigation investments.
- Financial risk management includes foreign currency risk analysis.
- Changes in equity involve share-based payments and transactions with non-controlling interests.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| South32 Limited (S32) ORDINARY FULLY PAID |
Materials |
$20,728 |
2025 Annual Report
|
28 Aug 2025 8:55AM |
$2.910 |
$4.620 |
risen by
58.76%
|
|
| Emyria Limited (EMD) ORDINARY FULLY PAID |
Health Care |
$39 |
2025 Annual General Meeting - Key Dates
|
28 Aug 2025 8:55AM |
$0.050 |
$0.048 |
fallen by
4%
|
|
| Westgold Resources Limited (WGX) ORDINARY FULLY PAID |
Materials |
$6,113 |
2025 Annual General Meeting - Key Dates
|
28 Aug 2025 8:54AM |
$3.370 |
$6.470 |
risen by
91.99%
|
|
| Ramsay Health Care Limited (RHC) ORDINARY FULLY PAID |
Health Care |
$9,764 |
Financial Results for the Year Ended 30 June 2025
|
28 Aug 2025 8:54AM |
$38.090 |
$42.300 |
risen by
11.05%
|
|
RHC - Price-sensitive ASX Announcement
Full Release
Key Points
- Solid performance in Australian and UK hospital businesses.
- Multi-year business transformation underway.
- Improved revenue indexation for FY25 and FY26 in Australia.
- Significant reduction in net profit after tax from continuing operations.
- Fully franked final dividend of 40¢ with a full year dividend of 80¢.
- Ongoing challenges with Elysium and Ramsay Santé.
- Progress on transformation priorities with key executive appointments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ramsay Health Care Limited (RHC) ORDINARY FULLY PAID |
Health Care |
$9,764 |
Financial Results for the Year Ended 30 June 2025
|
28 Aug 2025 8:54AM |
$38.090 |
$42.300 |
risen by
11.05%
|
|
RHC - Price-sensitive ASX Announcement
Full Release
Key Points
- Total segment revenue increased by 6.3% to AUD 17,844.6 million.
- EBIT from continuing operations declined by 29.2% to AUD 706.2 million.
- Net profit after tax from continuing operations decreased by 82.4% to AUD 46.3 million.
- Underlying profit after tax rose by 1.7% excluding non-recurring items.
- A non-cash impairment impacted the UK region negatively.
- Fully franked final dividend declared at 40.0¢ per share.
- Dividend Reinvestment Plan suspended indefinitely.
- Focus on optimizing shareholder returns and strategic priorities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.